Stem cell therapy for vascular disease

被引:35
作者
Adams, Benjamin [1 ]
Xiao, Qingzhong [1 ]
Xu, Qingbo [1 ]
机构
[1] Kings Coll London, Div Cardiovasc, James Black Ctr, London SE5 9NU, England
关键词
D O I
10.1016/j.tcm.2007.08.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial dysfunction/loss is a key event in the development of vascular diseases, including native atherosclerosis, angioplasty-induced restenosis, transplant arteriosclerosis, and vein bypass graft atherosclerosis. in challenge to the traditional concept that lost endothelial cells were replaced by neighboring endothelial replication, recent studies have shown that stem cells in blood and the vessel wall have the ability to repair endothelial cells after extensive loss. Concomitantly, accumulating data indicate that stem cell therapy is a promising option for the treatment of vascular diseases and might, in the future, contribute to tissue regeneration, that is, the restoration of endothelium lining the arteries to recover the function of the vascular system. In the present review, we will focus on the progress of stem cell therapy, discuss the mechanisms of stem cell differentiation into endothelial cells, and point out the clinical potential of stem cell therapy in the future. (Trends Cardiovasc Med 2007; 17:246-251) (c) 2007, Elsevier Inc.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 42 条
[1]   Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia [J].
Aicher, Alexandra ;
Rentsch, Markus ;
Sasaki, Ken-ichiro ;
Ellwart, Joachim W. ;
Faendrich, Fred ;
Siebert, Reiner ;
Cooke, John P. ;
Dimmeler, Stefanie ;
Heeschen, Christopher .
CIRCULATION RESEARCH, 2007, 100 (04) :581-589
[2]   Concise review: Stem cells, myocardial regeneration, and methodological artifacts [J].
Anversa, Piero ;
Leri, Annarosa ;
Rota, Marcello ;
Hosoda, Toru ;
Bearzi, Claudia ;
Urbanek, Konrad ;
Kajstura, Jan ;
Bolli, Roberto .
STEM CELLS, 2007, 25 (03) :589-601
[3]   Intracoronary infusion of progenitor cells is not associated with aggravated restenosis development or atherosclerotic disease progression in patients with acute myocardial infarction [J].
Assmus, Birgit ;
Walter, Dirk H. ;
Lehmann, Ralf ;
Honold, Joerg ;
Martin, Hans ;
Dimmeler, Stefanie ;
Zeiher, Andreas M. ;
Schaechinger, Volker .
EUROPEAN HEART JOURNAL, 2006, 27 (24) :2989-2995
[4]   Development of tissue engineered vascular grafts [J].
Campbell, G. R. ;
Campbell, J. H. .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2007, 8 (01) :43-50
[5]  
Gray B H, 1996, Vasc Med, V1, P287
[6]   Tissue-engineered blood vessels - Alternative to autologous grafts? [J].
Hoenig, MR ;
Campbell, GR ;
Rolfe, BE ;
Campbell, JH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (06) :1128-1134
[7]   Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice [J].
Hu, YH ;
Zhang, ZY ;
Torsney, E ;
Afzal, AR ;
Davison, F ;
Metzler, B ;
Xu, QB .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (09) :1258-1265
[8]   Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells [J].
Hu, YH ;
Davison, F ;
Ludewig, B ;
Erdel, M ;
Mayr, M ;
Url, M ;
Dietrich, H ;
Xu, QB .
CIRCULATION, 2002, 106 (14) :1834-1839
[9]   Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells [J].
Hu, YH ;
Davison, F ;
Zhang, ZY ;
Xu, QB .
CIRCULATION, 2003, 108 (25) :3122-3127
[10]   Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress [J].
Illi, B ;
Scopece, A ;
Nanni, S ;
Farsetti, A ;
Morgante, L ;
Biglioli, P ;
Capogrossi, MC ;
Gaetano, C .
CIRCULATION RESEARCH, 2005, 96 (05) :501-508